@article{4dcf7b40296a4d9db86ec34f06f0dbe4,
title = "The Future of Psychiatry Commission",
author = "Eyre, {Harris A.} and Arshya Vahabzadeh and Ryan Abbott and Cook, {Ian A.} and Michael Berk",
note = "Funding Information: HAE reports equity ownership and employment at CNSDose. AV is the Chief Medical Officer of Brain Power. IAC reports receiving a grant from Neosync, is employed at the University of California, Los Aangeles and Veterans Affairs is a consultant for Arctica Health, Cereve, and NeuroDetect, and was previously the Chief Medical Officer of NeuroSigma. IAC also has patents 8,380,315; 8,688,220; 8,700,164; 8,958,880; 9,238,139; 9,364,674; 9,511,223; 9,682,236, and other provisional filings licensed to NeuroSigma by the Regents of the University of California. MB reports personal fees from AstraZeneca, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Lundbeck, Janssen Cilag, Elsevier, Bioceuticals, and Servier. MB declares receiving grants from National Health and Medical Research Council, Stanley Medical Research Foundation, Medical Benefits Fund, Cooperative Research Centre, Simons Autism Foundation, Rotary Health, Cancer Council of Victoria, Meat and Livestock Board, Woolworths, Beyond Blue, and Geelong Medical Research Foundation. MB reports receiving personal fees outside of the submitted work from Bristol Myers Squibb, Eli Lilly, Pfizer, Organon, Novartis, Mayne Pharma, Sanofi Synthelabo, Wyeth, Bioadvantex, Merck, and Grunbiotics. MB also has a patent pending for use of N-acetylcysteine and related compounds for psychiatric indications. RA declares no competing interests.",
year = "2018",
month = jan,
doi = "10.1016/S2215-0366(17)30410-8",
language = "English (US)",
volume = "5",
pages = "13--78",
journal = "The Lancet Psychiatry",
issn = "2215-0366",
publisher = "Elsevier Limited",
number = "1",
}